Project Grant HT94252410572
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
- This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
- This federal Project Grant award of $1,314,065.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research on the dose-response relationship of acute traumatic brain injury (TBI) blood biomarkers with pathoanatomic neuroimaging findings. The project will be conducted by the University of California, San Francisco (UCSF) over a period of 3 years from September 1, 2025 to August 31, 2028. The research...
- This $608,353 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a longitudinal study by Craig Hospital's Research Department on resilience-related factors influencing psychosocial growth after traumatic brain injury. The study, titled "THRIVING AFTER TBI: A LONGITUDINAL INVESTIGATION OF RESILIENCE-RELATED FACTORS FOR PSYCHOSOCIAL GROWTH AFTER TRAUMATIC BRAIN INJURY," will be conducted over a 3-year...
- The Defense Health Agency awarded a $1,973,398 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Azevan Pharmaceuticals Inc. in Bethlehem, PA. The grant supports the development of a new drug to prevent the effects of mild traumatic brain injury (TBI) or concussion. The research project will be conducted over a 2-year period from June 2024 to June 2026. The goal is to advance the development of an innovative medical solution to address this critical...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- This federal Project Grant award, titled "COGNITIVE REHABILITATION FOR TREATMENT OF ANGER IN VETERANS WITH TBI AND PTSD," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $2,411,921.00 award to Duke University, effective August 1, 2025 through July 31, 2029, will support advanced biomedical research to develop innovative solutions for treating anger issues in military veterans with traumatic brain injury (TBI) and...
- This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
- This Project Grant award, valued at $1,322,705.00 and awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Craig Hospital to develop and evaluate a fatigue intervention program for adults with traumatic brain injury (TBI). The award will fund a multi-year research initiative to adapt and test the feasibility of an evidence-based fatigue management intervention for TBI patients, with the goal of improving functional...
- The Department of the Army Medical Command awarded a $718,090.00 Project Grant to the Kessler Foundation, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "NEUROBALANCE: NEUROMODULATION ENHANCED USE OF ROBOTIC BALANCE TRAINING TO IMPROVE POSTURAL CONTROL IN TBI", will support research to develop new treatments and interventions to improve postural control and rehabilitation outcomes for individuals with traumatic brain...
This $1,885,299.00 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Shepherd Center, Inc., a private non-profit hospital in Atlanta, Georgia, in expanding access to treatment for traumatic brain injury (MTBI) among veterans and service members with co-occurring substance use disorders. The grant, awarded on September 1, 2024, will fund specialized clinical care, research, and rehabilitation services focused on improving outcomes for individuals with neurological disabilities related to MTBI and substance use over the 4-year performance period through August 31, 2028. Shepherd Center has extensive experience delivering federally-funded healthcare and rehabilitation services, including past awards supporting spinal cord injury treatment, brain injury research, and development of assistive technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.9m | 6/7/24 |